The Munk Debates Podcast
Munk Dialogue with Andrew Coyne: Canada seeks to diversify its trade partnerships beyond the U.S
15 Jul 2025
What should we make of Trump's latest 35% tariff threat on Canada? Rudyard and Andrew agree that while this is not surprising given who we are dealing with, it's also not unique to Canada, with Europe and Mexico likewise getting hit with a tariff threat as well. We are not dealing with a normal interlocutor, and anybody who talks about Trump being a natural negotiator is not familiar with the trajectory of his career and many bankruptcies. Unfortunately for Mark Carney, the US holds most of the cards in cross border negotiations, and if recent history is any indication, there is no way of guaranteeing that Trump will live up to any treaty he signs. In the meantime, Europe and the Indo-Pacific have begun strengthening their relationships with other trade partners which will cost the US bargaining power in the future. But should Canada - in a similar bid to diversify trade - seek to strengthen business ties with China? And can Trump's tariffs - which have already paid off a portion of the US treasury's deficit - actually work as intended and chip away at America's ballooning debt?
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare